Dossier
Apotex
Coverage of Apotex in the Nexus archive.
- Apotex, Backers Raise $932 Million in Canada IPO Priced at Top
Apotex and its backers raised $932 million in a Canada IPO priced at the top. The offering was oversubscribed, reflecting strong investor demand.
- Drugmaker Apotex Files for Canada IPO Showing Revenue Jump
Drugmaker Apotex has filed for an initial public offering (IPO) in Canada, accompanied by a reported revenue increase. The company's Toronto-based facility is highlighted in the article.